Synthesis of novel C3-linked β-carboline-pyridine derivatives employing khronke reaction: DNA-binding ability and molecular modeling studies

Letters in Drug Design and Discovery

Volumn 13, Issue 4, 2016, Pages 335-342

  Shankaraiah, Nagula ^a   Sharma, Pankaj ^a   Pedapati, Srinivas ^a   Nekkanti, Shalini ^a   Srinivasulu, Vunnam ^b   Kumar, Niggula Praveen ^a,b   Kamal, Ahmed ^b  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

DNA intercalation; DNA binding affinity; Khronke reaction; Molecular modeling; Terpyridine; Carbolines

Indexed keywords

BETA CARBOLINE PYRIDINE DERIVATIVE; DOXORUBICIN; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHEMICAL REACTION; DNA BINDING; DNA HELIX; DRUG SYNTHESIS; INTERACTIONS WITH DNA; KHRONKE REACTION; MOLECULAR DOCKING; PRIORITY JOURNAL;

EID: 84961642297     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018081304160303180050     Document Type: Article

References (47)

1. Cao, R.; Peng, W.; Wang, Z.; Xu, A. β-Carboline alkaloids: biochemical and pharmacological functions. Curr. Med. Chem., 2007, 14, 479-500.
2. Xiao, S.; Lin, W.; Wang, C.; Yang, M. Synthesis and biological evaluation of DNA targeting flexible side-chain substituted β-carboline derivatives. Bioorg. Med. Chem. Lett., 2001, 11, 437-441.
3. Deveau, A. M.; Labroli, M. A.; Dieckhaus, C. M.; Barthen, M. T.; Smith, K. S.; Macdonald, T. L. The synthesis of amino-acid functionalized β-Carbolines as topoisomerase II inhibitors. Bioorg. Med. Chem. Lett., 2001, 11, 1251-1255.
4. Song, Y.; Wang, J.; Teng, S. F.; Kesuma, D.; Deng, Y.; Duan, J.; Wang, J. H.; Qi, R. Z.; Sim, M. M. β-Carbolines as specific inhibitors of cyclin-Dependent kinases. Bioorg. Med. Chem. Lett., 2002, 12, 1129-1132.
5. Song, Y.; Kesuma, D.; Wang, J.; Deng, Y.; Duan, J.; Wang, J. H.; Qi, R. Z. Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine Biochem. Biophys. Res. Commun., 2004, 317, 128-132.
6. Castro, A. C.; Dang, L. C.; Soucy, F.; Grenier, L.; Mazdiyasni, H.; Hottelet, M.; Parent, L.; Pien, C.; Palombella, V.; Adams, J. Novel IKK inhibitors: β-carbolines Bioorg. Med. Chem. Lett., 2003, 13, 2419-2422.
7. Trujillo, J. I.; Meyers, M. J.; Anderson, D. R.; Hegde, S.; Mahoney, M. W.; Vernier, W. F.; Buchler, I. P.; Wu, K. K.; Yang, S.; Hartmann, S. J.; Reitz, D. B. Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinaseactivated protein kinase 2 (MK-2) Bioorg. Med. Chem. Lett., 2007, 17, 4657-4663.
8. Barsanti, P. A.; Wang, W.; Ni, Z.; Duhl, D.; Brammeier, N.; Martin, E. The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5. Bioorg. Med. Chem. Lett., 2010, 20, 157-160.
9. Chourasiya, R. K.; Raghuram A. R.; Kishore, A. R.; Pharmacophore modeling and QSAR analysis of novel β-carboline derivatives as antitumor agents. Lett. Drug Des. Discov., 2013, 13, 572-584.
10. Meester, C. Genotoxic potential of β-Carboline: a review. Mutat. Res., 1995, 339, 139-153.
11. Hayashi, K.; Nagao, M.; Sugimura, T. Interactions of norharman and harman with DNA. Nucleic Acid Res., 1977, 4, 3679-3686.
12. Funayama, Y.; Nakasato, K.; Wakabayashi, K.; Nagao, M.; Shimoi, K.; Ohira, T.; Hasegawa, S.; Saijo, N. The β-carboline alkaloid harmine inhibits telomerase activity of MCF-7 cells by downregulating hTERT mRNA expression accompanied by an accelerated senescent phenotype. Mutat. Res., 1996, 349, 183-191.
13. Feigon, J.; Denny, W. A.; Leupin, W.; Kearns, D. R. Interactions of antitumor drugs with natural DNA: proton NMR study of binding mode and kinetics. J. Med. Chem., 1984, 27, 450-465.
14. Chen, Q.; Chao, R.; Chen, H.; Hou, X.; Yan, H.; Zhou, S.; Peng, W.; Xu, A. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int. J. Cancer., 2004, 114, 675-682.
15. Chen, Z.; Cao, R.; Yu, L.; Shi, B.; Sun, J.; Guo, L.; Ma, Q.; Yi, W.; Song, X.; Song, H. Synthesis, cytotoxic activities and DNA binding properties of β-carboline derivatives. Eur. J. Med. Chem., 2010, 45, 4740-4745.
16. Kiuru, P.; Yli-Kauhaluoma, J.; Chattopadhyay, S. K. Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2011, 267-269.
17. Baumann, M.; Baxendale, I. R. An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles. Beilstein J. Org. Chem., 2013, 9, 2265-2319.
18. Evdokimov, N. M.; Magedov, I. V.; Kireev, A. S.; Kornienko, A. One-step, three-component synthesis of pyridines and 1, 4-dihydropyridines with manifold medicinal utility. Org. Lett., 2006, 8, 899-902.
19. Anderson, D. R.; Stehle, N. W.; Kolodziej, S. A.; Reinhard, E. J. PCT Int. Appl. WO 2004055015 A1 20040701, 2004.
20. Nirschl, A. A.; Hamann, L. G. US Pat. Appl. Publ. US 2005182105 A1 20050818, 2005.
21. Chen, H.; Zhang, W.; Tam, R.; Raney, A. K. PCT Int. Appl. WO 2005058315 A1 20050630, 2005.
22. Levy, S. B.; Alekshun, M. N.; Podlogar, B. L.; Ohemeng, K.; Verma, A. K.; Warchol, T.; Bhatia, B.; Bowser, T.; T. Grier, T. US Pat. Appl. Publ. US 2005124678 A1 20050609, 2005.
23. Chelucci, G. Synthesis and application in asymmetric catalysis of camphor-based pyridine ligands. Chem. Soc. Rev., 2006, 35, 1230-1243.
24. Arena, C. G.; Arico, G. G. Chiral heterobidentate pyridine ligands for asymmetric catalysis. Curr. Org. Chem., 2010, 14, 546-580.
25. Zelewsky, A. V. Stereoselective synthesis of coordination compounds. Coord. Chem. Rev., 1999, 190, 811-825.
26. Lowe, G.; Droz, A. S.; Park, J. J.; Weaver, G. W. The design and synthesis of bis-[4'-azido-2, 2':6', 2"-terpyridine platinum (II)] complexes with rigid and extended linkers for studying the topology of DNA by photoaffinity labeling. Bioorg. Chem., 1999, 27, 477-486.
27. Zhou, F. X.; Zheng, Z.; Zhou, H. P.; Ke, W. Z.; Wang, J. Q.; Yu, Z. P.; Jin, F.; Yang, J. X.; Wu, J. Y.; Tian, Y. P. A. A new 2, 2prime:6prime, 2primeprime-terpyridine-based ligand and its complexes: structures, photophysical properties and DFT calculations to evaluate the halogen effect on the TPA. Cryst. Eng. Comm., 2012, 14, 5613-562.
28. Indumathy, R.; Kanthimathi, M.; Weyhermuller, T.; Nair, B. U. Cobalt complexes of terpyridine ligands: Crystal structure and nuclease activity Polyhedron., 2008, 27, 3443-3450.
29. 2+: Synthesis, crystal structure, DNA binding and cytotoxicity activity. Polyhedron., 2012, 31, 638-648.
30. Liang, L. J.; Zhao, X. J.; Huang, C. Z. Zn (II) complex of terpyridine for the highly selective fluorescent recognition of pyrophosphate. Analyst., 2012, 137, 953-958.
31. Carter, P. J.; Cheng, C. C.; Thorp, H. H. Oxidation of DNA and RNA by oxoruthenium (IV) metallointercalators: Visualizing the recognition properties of dipyridophenazine by high-resolution electrophoresis. J. Am. Chem. Soc., 1998, 120, 632-642.
32. Kim, D. S. H. L.; Ashendel, C. L.; Zhou, Q.; Chang, C. T.; Lee, E. S.; Chang, C. J. Novel protein kinase C inhibitors: α-terthiophene derivatives. Bioorg. Med. Chem. Lett., 1998, 8, 2695-2698.
33. Basnet, A.; Thapa, P.; Karki, R.; Na, Y.; Jahng, Y.; Jeong, B. S.; Jeong, T. C.; Lee, C. S.; Lee, E. S. 2, 4, 6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Bioorg. Med. Chem., 2007, 15, 4351-4359.
34. Son, J. K.; Zhao, L. X.; Basnet, A.; Thapa, P.; Karki, R.; Na, Y.; Jahng, Y.; Jeong, T. C.; Jeong, B. S.; Lee, C. S.; Lee, E. S. Synthesis of 2, 6-diaryl-substituted pyridines and their antitumor activities. Eur. J. Med. Chem., 2008, 43, 675-682.
35. Karki, R.; Park, C.; Jun, K. Y.; Jee, J. G.; Lee, J. H.; Thapa, P.; Kadayat, T. M.; Kwon, Y.; Lee, E. S. Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2, 4, 6-triphenyl pyridines as potent and selective topoisomerase II inhibitors. Eur. J. Med. Chem., 2014, 84, 555-565.
36. Kamal, A.; Reddy, J. S.; Ramaiah, M. J.; Dastagiri, D.; Bharathi, E. V.; Sagar, M. V. P.; Pushpavalli, S. N. C. V. L.; Ray, P.; Bhadra, M. P. Design, synthesis and biological evaluation of imidazopyridine/pyrimidine-chalcone derivatives as potential anticancer agents. Med. Chem. Commun., 2010, 1, 355-360.
37. Shankaraiah, N.; Silva, W. A.; Andrade, C. K. Z.; Santos, L. S. Enantioselective total synthesis of (S) - (-)-Quinolactacin B. Tetrahedron Lett., 2008, 49, 4289-4291.
38. Shankaraiah, N.; Santos, L. S. Enantioselective total synthesis of pyrroloquinolone as a potent PDE5 inhibitor. Tetrahedron Lett., 2009, 50, 520-523.
39. Silva, W. A.; Rodrigues, M. T.; Shankaraiah, N.; Ferreira, R. B.; Andrade, C. K. Z.; Pilli, R. A.; Santos, L. S. Novel supramolecular palladium catalyst for the asymmetric reduction of imines in aqueous media. Org. Lett., 2009, 11, 3238-3241.
40. Kamal, A.; Srinivasulu, V.; Nayak, V. L; Sathish, M.; Shankaraiah, N.; Bagul, C.; Reddy, N. V. S; Rangaraj, N.; Nagesh, N. Design and synthesis of C3-pyrazole/chalcone-linked β-carboline hybrids: Antitopoisomerase I, DNA-interactive, and apoptosis-inducing anticancer agents. Chem. Med. Chem., 2014, 9, 2084-2098.
41. Shankaraiah, N.; Nekkanti, S.; Chudasama, K. J.; Senwar, K. R.; Sharma, P.; Jeengar, M. K.; Naidu, V. G. M.; Srinivasulu, V.; Kamal, A. Design, synthesis and anticancer evaluation of tetrahydro-β-Carboline-hydantoin hybrids. Bioorg. Med. Chem. Lett., 2014, 24, 5413-5417.
42. Kamal, A.; Reddy, K. L.; Devaiah, V.; Shankaraiah, N.; Kumar, M. S.; Reddy, G. S. K. Synthesis and biological activity of C-8 fluoroaryl substituted pyrimidine linked-pyrrolobenzodiazepine conjugates. Lett. Drug Des. Discov., 2005, 2, 55-61.
43. Kamal, A.; Shankaraiah, N.; Reddy, K. L.; Devaiah, V.; Juvekar, A.; Sen, S. Design, synthesis and biological activity of A-C8/C-C2-Linked 6-chloropurine-pyrrolobenzodiazepine hybrids as anticancer agents. Lett. Drug Des. Discov., 2007, 4, 596-604.
44. Kamal, A.; Kumar, P. P.; Khan, M. N. A.; Sheshadri, B. N.; Srinivas, O. Hybrid pharmacophore design and synthesis of naphthalimide-benzimidazole conjugates as potential anticancer agents. Lett. Drug Des. Discov., 2015, 12, 374-384.
45. McCoubrey, A.; Latham, H. C.; Cook, P. R.; Rodger, A.; Lowe, G. 4-Picoline-2, 2':6', 2"-terpyridine-platinum (II) - a potent intercalator of DNA. FEBS Lett., 1996, 12, 73-78.
46. Patel, K. K.; Plummer, E. A.; Darwish, M.; Rodger, A.; Hannon, M. J. Aryl substituted ruthenium bis-terpyridine complexes: intercalation and groove binding with DNA. J. Inorg. Biochem. 2002, 91, 220-229.
47. Xiao, S.; Lin, W.; Wang, C.; Yang, M. Synthesis and biological evaluation of DNA targeting flexible side-chain substituted β-carboline derivatives. Bioorg. Med. Chem. Lett., 2001, 11, 437-441.